CivicaRx wants to change drug costs by working with pharma
CivicaRx, the not-for-profit entity created last year by a group of health systems and hospitals, is planning to achieve its goals of lowering drug prices and addressing shortages in hospitals by working directly with pharmaceutical companies and buying drugs, Bloomberg reported.
When the entity first came to fruition, its stated goal was to manufacture its own drugs after hospitals faced shortages for many common drugs. For now, it seems CivicaRx will serve as a marketplace entity, buying drugs from pharmaceutical companies and acting as a go-between for hospitals, according to Bloomberg.
“With that critical need, almost a national drug-shortage crisis, we had to discover what was the fastest way to get products into the market,” CivicaRx CEO Martin VanTrieste told Bloomberg.
See the full story below: